These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26113973)

  • 21. Pressure-response analysis of anesthetic gases xenon and nitrous oxide on urate oxidase: a crystallographic study.
    Marassio G; Prangé T; David HN; Santos JS; Gabison L; Delcroix N; Abraini JH; Colloc'h N
    FASEB J; 2011 Jul; 25(7):2266-75. PubMed ID: 21421845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A closed-circuit neonatal xenon delivery system: a technical and practical neuroprotection feasibility study in newborn pigs.
    Chakkarapani E; Thoresen M; Hobbs CE; Aquilina K; Liu X; Dingley J
    Anesth Analg; 2009 Aug; 109(2):451-60. PubMed ID: 19608817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of xenon and nitrous oxide gases on alcohol relapse.
    Vengeliene V; Bessiere B; Pype J; Spanagel R
    Alcohol Clin Exp Res; 2014 Feb; 38(2):557-63. PubMed ID: 24118055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
    Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats.
    Thrall KD; Soelberg JJ; Weitz KK; Woodstock AD
    J Toxicol Environ Health A; 2002 Jul; 65(13):881-96. PubMed ID: 12133235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling.
    Takano R; Murayama N; Horiuchi K; Kitajima M; Kumamoto M; Shono F; Yamazaki H
    Regul Toxicol Pharmacol; 2010 Nov; 58(2):252-8. PubMed ID: 20600458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A.
    Yang X; Doerge DR; Teeguarden JG; Fisher JW
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):442-56. PubMed ID: 26522835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Impairment of gas exchange in acute lung injury].
    Yamaguchi K; Mori M; Kawai A; Asano K; Takasugi T; Umeda A; Yokoyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):133-44. PubMed ID: 2033887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inert gas transport in blood and tissues.
    Baker AB; Farmery AD
    Compr Physiol; 2011 Apr; 1(2):569-92. PubMed ID: 23737195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
    Thrall KD; Woodstock AD; Kania MR
    J Toxicol Environ Health A; 2004 Apr; 67(7):525-36. PubMed ID: 15129550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects.
    Kaplan N; Garner C; Hafkin B
    Eur J Pharm Sci; 2013 Nov; 50(3-4):440-6. PubMed ID: 23988847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction.
    Liu F; Zhuang X; Yang C; Li Z; Xiong S; Zhang Z; Li J; Lu C; Zhang Z
    Biopharm Drug Dispos; 2014 Jul; 35(5):296-307. PubMed ID: 24647883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an inhalation physiologically based pharmacokinetic (PBPK) model for 2,2, 4-trimethylpentane (TMP) in male Long-Evans rats using gas uptake experiments.
    El-Masri HA; Dowd S; Pegram RA; Harrison R; Yavanhxay SJ; Simmons JE; Evans M
    Inhal Toxicol; 2009 Dec; 21(14):1176-85. PubMed ID: 19922404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.